Cipla Q1 PAT may dip 15% at Rs 340 cr: Nirmal Bang

Nirmal Bang has come out with its first quarter (April-June) earnings estimates for the pharmaceutical sector. The brokerage house expects Cipla to report a 26.9 percent growth quarter-on-quarter (fall of 15.3 percent year-on-year) in net profit at Rs 339.6 crore.

Revenues are expected to increase by 11.1 percent Q-o-Q (up 11.6 percent Y-o-Y) to Rs 2,184.7 crore, according to Nirmal Bang. Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 19.5 percent Q-o-Q (down 9.4 percent Y-o-Y) to Rs 489.3 crore. EBITDA margin or operating profit margin is likely to be at 22.4 percent in June quarter as against 20.8 percent in March quarter and 27.6 percent in a year ago period.